Clinical Trials Sponsored by NEXTGEN Bioscience

Total 1890 results

Daré Bioscience, Inc.

Completed

Study of DARE-HRT1 Over 12 Weeks in Healthy PostMenopausal Women (DARE-HRT1)

Vasomotor Symptoms | Vulvovaginal Atrophy

Australia
Biofrontera Bioscience GmbH

Completed

Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp

Keratosis | Actinic Keratosis | Keratosis, Actinic

United States
Aadi Bioscience, Inc.

Completed

A Phase 2 Study of Nab-sirolimus (ABI-009) in Patients With Advanced Malignant PEComa (AMPECT)

Malignant PEComa

United States
Entrinsic Bioscience Inc.

Terminated

Effects of an Amino Acid Mixture on Gastrointestinal Function, Inflammation and Fluid Balance: A Pilot Study in Patients With Inflammatory Bowel Disease

Inflammatory Bowel Diseases | Ileostomy - Stoma | Short Bowel Syndrome

United States
Meridian Bioscience, Inc.

Completed

Equivalence of New Breath AnalyzerCompared to Currently BreathID System in Assessment of Liver Function

Healthy Volunteers | Chronic Liver Disease (CLD)

Israel
Aadi Bioscience, Inc.

Active, not recruiting

ABI-009, an mTOR Inhibitor, for Patients With Severe Pulmonary Arterial Hypertension

Pulmonary Hypertension

United States
Themis Bioscience GmbH

Completed

Zika-Vaccine Dose Finding Study Regarding Safety, Immunogenicity and Tolerability (V186-001)

Zika Virus

Austria
Quadram Institute Bioscience

Enrolling by invitation

The QIB Colon Model

Human Gut Microbiota

United Kingdom
Aadi Bioscience, Inc.

Withdrawn

ABI-009 (Nab-sirolimus) in Patients With Genetically-confirmed Leigh or Leigh-like Syndrome

Leigh Syndrome
Themis Bioscience GmbH

Completed

Phase II Study to Evaluate Safety and Immunogenicity of a Chikungunya Vaccine (MV-CHIK-202)

Chikungunya Virus Infection

Austria, Germany
Themis Bioscience GmbH

Completed

Safety, Tolerability and Long-term Immunogenicity of Different Formulations of a Chikungunya Vaccine (V184-005)

Chikungunya Virus Infection

United Kingdom
Meridian Bioscience, Inc.

Completed

Validation of the GenePOC Strep A, C/G Assay for Detecting Group A, C and G β-hemolytic Streptococcus From Throat Swabs.

Pharyngitis, Infective

United States, Canada
Meridian Bioscience, Inc.

Completed

Validation of the GenePOC GBS Assay for the Detection of the Cfb Gene From Streptococcus Agalactiae Strains

Streptococcus Agalactiae Infection

Canada, United States
Lumen Bioscience, Inc.

Completed

Safety and Pharmacokinetic Study of LMN-101 in Healthy Volunteers

Campylobacter Jejuni Infection

Australia
Sidero Bioscience, LLC

Completed

BioFe, Medical Food for the Dietary Management of Iron Deficiency

Iron Deficiency

United States
SinoMab BioScience Ltd

Completed

A Study to Evaluate the Safety and Efficacy of SM03 in Patients With Rheumatoid Arthritis Receiving Methotrexate

Rheumatoid Arthritis

China
Neurotrope Bioscience, Inc.

Completed

A Study Assessing Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease

Alzheimer's Disease

United States
Proove Bioscience, Inc.

Unknown

Observational Study of the Impact of Genetic Testing on Healthcare Decisions and Care in Interventional Pain Management (MOSAIC)

Pain | Back Pain | Musculoskeletal Pain | Chronic Pain | Neck Pain | Neuropathic Pain | Pain, Intractable | Nociceptive Pain

United States
Biofrontera Bioscience GmbH

Completed

Evaluation of Efficacy and Safety of BF-200 ALA Used With Photodynamic Therapy in Patients With Actinic Keratosis.

Actinic Keratosis
Quadram Institute Bioscience

Completed

The Effects of Apple Derived Flavanols on Cardiovascular Disease Risk (FLAVASCULAR Study) (FLAVASCULAR)

Blood Pressure

United Kingdom
Proove Bioscience, Inc.

Unknown

A Study of the Impact of Genetic Testing on Clinical Decision Making and Patient Care (REVOLUTION)

Mental Disorders | Cardiovascular Diseases | Pain | Diabetes Mellitus, Type 2 | Arthritis | Chronic Pain

United States
Euthymics BioScience, Inc.

Completed

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Major Depressive Disorder

United States
ICON Bioscience Inc

Terminated

Efficacy and Safety Study of IBI-10090 in Cataract Surgery Patients

Ocular Inflammation

United States
Fruitura Bioscience Ltd.

Completed

Pharmacokinetics of Resveratrol Comprising Products

Healthy

Israel
Quadram Institute Bioscience

Completed

Effect of Apple Flavanols on Risk of Cardiovascular Disease (FLAVO)

Cardiovascular Disease

United Kingdom
Quadram Institute Bioscience

Completed

Broccoli, Peas and PIN

Prostatic Intraepithelial Neoplasia
LigaChem Biosciences, Inc.
AntibodyChem Biosciences, Inc.

Recruiting

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

Advanced Solid Tumors

United States, Canada
Zomagen Biosciences, Ltd

Completed

A Study to Evaluate VTX2735 in Patients With Cryopyrin-associated Periodic Syndrome (Explore)

Cryopyrin Associated Periodic Syndrome

United States
Brii Biosciences, Inc.

Withdrawn

A Safety and Efficacy Study of Human Monoclonal Antibodies, BRII-196 and BRII-198 for the Treatment of Patients With COVID-19

COVID-19

China
Walden Biosciences

Not yet recruiting

Study of WAL0921 in Patients With Glomerular Kidney Diseases

Diabetic Nephropathies | Minimal Change Disease | Primary Focal Segmental Glomerulosclerosis | Primary Membranous Nephropathy | Primary Immunoglobulin A Nephropathy
MBX Biosciences

Recruiting

Safety, Pharmacokinetics and Efficacy of MBX 2109 in Patients With Hypoparathyroidism

Hypoparathyroidism

United States
Xeno Biosciences

Not yet recruiting

A Phase 1b Study to Evaluate the Safety of XEN-101

Obesity
Assembly Biosciences

Not yet recruiting

A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-4334 in Subjects With Chronic Hepatitis B Virus Infection

Chronic Hepatitis B
Senti Biosciences

Recruiting

SENTI-202: Off-the-shelf Logic Gated CAR NK Cell Therapy in Adults With CD33 and/or FLT3 Blood Cancers Including AML/MDS

AML/MDS | CD33 Expressing Hematological Malignancies | FLT3 Expressing Hematological Malignancies

United States, Australia
Euromi Biosciences

Recruiting

Prospective Observational Clinical Follow-up of Euromi Biosciences Pre-filled Silicone Gel Breast Implants (ELEGANT)

Breast Implant Rupture | Breast Implant; Complications

France
IDEAYA Biosciences

Recruiting

IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal Melanoma

Metastatic Uveal Melanoma

United States, Canada, Israel, Spain, Australia, Germany, France, Italy, United Kingdom, Netherlands, Belgium, Poland, Switzerland
IDEAYA Biosciences

Recruiting

(Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma

Uveal Melanoma

United States, Australia, Canada, Netherlands, Italy, Germany, France, United Kingdom
Neurocrine Biosciences

Recruiting

Study of the Effectiveness of Valbenazine on Patient- and Clinician-Reported Outcomes in Participants With Tardive Dyskinesia

Schizophrenia | Schizoaffective Disorder | Bipolar Disorder | Tardive Dyskinesia | Major Depressive Disorder

United States
Sanguine Biosciences

Recruiting

Prospective Collection of Whole Blood From Active Non-Small Cell Lung Cancer Patients for Supplemental Research

Non Small Cell Lung Cancer

United States
Neurocrine Biosciences

Recruiting

Efficacy, Safety, Tolerability, and Pharmacokinetics of NBI-1117568 in Adults With Schizophrenia

Schizophrenia

United States
Antiva Biosciences

Recruiting

A Study of ABI-2280 Vaginal Tablet in Participants With Cervical Intraepithelial Neoplasia

Cervical Intraepithelial Neoplasia

Australia, South Africa
Aura Biosciences

Recruiting

A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer

Muscle-Invasive Bladder Carcinoma | Non-muscle-invasive Bladder Cancer

United States
Neurocrine Biosciences

Recruiting

Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Dyskinesia Due to Cerebral Palsy

Cerebral Palsy | Dyskinesia

United States, Argentina, Poland, Spain, Australia, Brazil, Italy, Portugal
Neurocrine Biosciences

Recruiting

Journey Study: Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as Adjunctive Treatment for Schizophrenia

Schizophrenia

United States, Bulgaria, Serbia
RaND Biosciences

Not yet recruiting

A Phase 1/2 Study of SC-43 in Combination With Cisplatin

Advanced Biliary Tract Cancer | Advanced Non-small-cell Lung Cancer
IDEAYA Biosciences

Recruiting

Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

Colorectal Cancer | Metastatic Uveal Melanoma | Cutaneous Melanoma | Other Solid Tumors

United States, Australia, Canada
Aura Biosciences

Recruiting

A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma

Choroidal Melanoma | Indeterminate Lesions of Eye

United States
Sanguine Biosciences

Terminated

Prospective Collection of Biospecimen in Pediatric Patients and Adult Guardians Diagnosed With Glycogen Storage Disease Type 1B (GSD1b)

Glycogen Storage Disease Type IB

United States
Sanguine Biosciences

Terminated

Whole Blood Biospecimen Collection for Subjects With Fanconi Anemia

Fanconi Anemia

United States
Sanguine Biosciences

Terminated

Whole Blood Biospecimen Collection for Subjects With Chronic Granulomatous Disease (CGD)

Chronic Granulomatous Disease

United States

3

Subscribe